Home Am I at Risk? Aging, Menopause, and Your Heart

Aging, Menopause, and Your Heart

What is menopause?

Menopause is a normal change in a woman's life when her period stops. That's why some people call menopause “the change of life.” During menopause, a woman's body slowly makes less of the hormones estrogen and progesterone. This usually happens between the ages of 45 and 55. A woman has reached menopause when she has not had a period for 12 months in a row, and there are no other causes for this change (such as pregnancy). Menopause is considered early or premature if it occurs before age 40.16 The average age of menopause is 51 years.17

During and after menopause, a woman's ovaries no longer produce estrogen, though her body still produces a small amount of this hormone. It is partly this lack of estrogen that increases a woman's risk for developing heart disease.

What is surgical menopause?

Surgical menopause is when your periods stop because of the surgical removal of the uterus. This procedure is called a hysterectomy, and it may also involve removing one or both ovaries. Your periods stop once your uterus is removed; however, your body will continue to produce estrogen if your ovaries are left intact .17, 18 Eventually you will stop producing estrogen with natural menopause probably a year or 2 earlier than if you still had a uterus.

You may also have surgery to remove your ovaries that leaves your uterus in place. This procedure is called oophorectomy. If both ovaries are removed, you will enter menopause. If only one is removed, you will continue to have periods until natural menopause. In addition, some medical treatments such as radiation treatment (e.g., for cancer) may damage the ovaries and trigger menopause.

Each year, more than 600,000 hysterectomies are performed in the US. About one third of women in the United States have had a hysterectomy by age 60.18 Black, Hispanic, and American-Indian women are significantly more likely to have a hysterectomy than white women, while Asian/Pacific Islander women are less likely.17

Should I consider hormone therapy to reduce my risk of heart disease?

No. Even though your body's natural estrogen can help protect your heart, studies have shown that simply taking replacement estrogen doesn't have the same benefits. In fact, in some studies, women taking hormone therapy actually had a higher risk of heart disease.19-21 Scientists now think that the estrogen a woman's own body produces acts differently than manufactured forms of the hormone. Ongoing trials of hormone therapy are investigating whether these findings are true for all postmenopausal women and all types of hormone therapy. One recent study indicated that heart risk did not increase, and may even have dropped slightly, in younger woman who start taking hormones soon after menopause.22

For more information, see our article on Hormone therapy.

How will menopause affect my risk of developing heart disease?

Whether or not you have gone through menopause is more important than your age in terms of your risk of heart disease. Heart disease rates in women after menopause are 2 to 3 times that of premenopausal women of the same age.6 Among the 2,873 women in the Framingham Heart Study, heart disease rates in postmenopausal women aged 45 to 54 were twice that of premenopausal women of the same age.23

Early or premature menopause has been linked to early death. A 1999 study of more than 6,000 women found that those who underwent early menopause (ages 35 to 40) had a greater likelihood of dying early from any cause and specifically dying from heart disease.24 Early surgical menopause may also increase a woman's risk for heart attack and stroke, particularly if the ovaries are removed.1, 25

Does age or menopause have an effect on other risk factors for heart disease?

Yes. The risk of developing diabetes, high blood pressure, and high cholesterol increases with age. Almost all risk factors become more common in women than in men at older ages because women live longer than men. Only smoking remains more common in older men.8

Menopause, either natural or surgical, increases your levels of total cholesterol. It also increases levels of chemicals involved in the body's immune system response, such as interleukin-6, and it increases levels of homocysteine, a protein linked to the development of damaged arteries.26-29 Both of these compounds may increase your risk for heart disease.

The risk of developing metabolic syndrome—a collection of risk factors including a large waistline, higher than normal blood sugar, blood pressure, and triglycerides—is higher in postmenopausal women than premenopausal women. 30

See also:
Menopause & Stroke Risk
Menopause & Heart Failure Risk

References

  1. Hsia J, Barad D, Margolis K, et al. Usefulness of prior hysterectomy as an independent predictor of Framingham Risk Score (the Women's Health Initiative). Am J Cardiol. 2003;92(3):264.
  2. Heart Disease and Stroke Statistics: 2006 Update. Dallas, Texas: American Heart Association and the American Stroke Association; 2006.
  3. Rexrode KM, Manson JE, Lee I, et al. Sex hormone levels and risk of cardiovascular events in postmenopausal women. Circulation. 2003;108:1688-1693.
  4. Waters DD, Gordon D, Rossouw JE, et al. Current Status and Future Research Direction Report of the National Heart, Lung and Blood Institute Workshop. Paper presented at: Women's Ischemic Syndrome Evaluation, 2004.
  5. National Cholesterol Education Program Expert Panel on Detection E, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Full Report. Bethesda, MD: U.S. Department of Health and Human Services: National Institutes of Health, National Heart, Lung, and Blood Institute.; September 2002.
  6. Heart Disease and Stroke Statistics - 2005 Update: American Heart Association and the American Stroke Association; 2005.
  7. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet. Jan 9 1999;353(9147):89-92.
  8. Kannel WB, Levine BS. Coronary heart disease risk in people 65 years of age and older. Prog Cardiovasc Nurs. 2003;18(3):135-140.
  9. Rathore SS, Mehta RH, Wang Y, Radford MJ, Krumholz HM. Effects of age on the quality of care provided to older patients with acute myocardial infarction. Am J Med. March 2003;114(4):333-335.
  10. Frishman WH. Treatment of myocardial ischemia and myocardial infarction in the elderly. South Med J. Oct 1993;86(10):2S29-37.
  11. Wenger NK, Helmy T, Patel AD, Lerakis S. Evidence-based Management of Coronary Artery Disease in the Elderly -- Current Perspectives. Medscape General Medicine. April 13, 2005 2005;7(2).
  12. Tresch DD, Alla HR. Diagnosis and management of myocardial ischemia ( angina) in the elderly patient. Am J Geriatr Cardiol. Nov-Dec 2001;10(6):337-344.
  13. MacMahon S, Rodgers A. The effects of blood pressure reduction in older patients: an overview of five randomized controlled trials in elderly hypertensives. Clin Exp Hypertens. Nov 1993;15(6):967-978.
  14. Lewis SJ, Moye LA, Sacks FM, et al. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial. Ann Intern Med. Nov 1 1998;129(9):681-689.
  15. Kaiser C, Kuster GM, Erne P, et al. Risks and benefits of optimised medical and revascularisation therapy in elderly patients with angina--on-treatment analysis of the TIME trial. Eur Heart J. Jun 2004;25(12):1036-1042.
  16. Stedmen's Medical Dictionary. 27 ed. Baltimore, MD: Lippincott, Williams & Wilkins; 2000.
  17. Howard B, Kuller L, Langer R, et al. Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy. Circulation. 2005;111:1462-1470.
  18. Hysterectomy. US Department of Health and Human Services. Available at: http://www.4woman.gov/faq/hysterectomy.htm#2. Accessed Nov 3, 2005.
  19. Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force. Ann Intern Med. May 17 2005;142(10):855-860.
  20. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. Jama. Jul 17 2002;288(3):321-333.
  21. Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Jama. Aug 19 1998;280(7):605-613.
  22. Rossouw JE, Prentice RL, Manson JE, et al. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. Apr 4 2007;297(13):1465-1477.
  23. Gordon T, Kannel WB, Hjortland MC, McNamara PM. Menopause and coronary heart disease. The Framingham Study. Ann Intern Med. Aug 1978;89(2):157-161.
  24. Jacobsen BK, Knutsen SF, Fraser GE. Age at natural menopause and total mortality and mortality from ischemic heart disease: the Adventist Health Study. J Clin Epidemiol. Apr 1999;52(4):303-307.
  25. Brett K. Can hysterectomy be considered a risk factor for cardiovascular disease. Circulation. 2005;111:1456-1458.
  26. Akahoshi M, Soda M, MNakashima MS, Shimaoka K, Seto S, Yano K. Effects of menopause on trends of serum cholesterol, blood pressure, and body mass. Circulation. 1996;94:61-66.
  27. Cantatore F, Loverro G, Ingrosso A, et al. Effects of estrogen replacement on bone metabolism and cytokines in surgical menopause. Clin Rheumatol. 1995;14:157-160.
  28. Cioff M, Esposito K, Vaietri M, et al. Cytokine pattern in postmenopause. Maturitas. 2002;41:187-192.
  29. Davison S, Davis S. New markers for cardiovascular disease risk in women: Impact of endogenous estrogen status and exogenous postmenopausal hormone therapy. J Clin Endocrinol Metab. 2003;88:2470-2478.
  30. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med. Feb 24 2003;163(4):427-436.

Filed in Am I at Risk? > Age & Menopause


SEO by AceSEF
Banner
Banner